| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |